The Community Resource in Targeted Therapies
Driving Knowledge. Empowering Change. Optimizing Outcomes.
ONCAlert | Upfront Therapy for mRCC
Videos  >  

The Need for Novel Therapies in Mantle Cell Lymphoma

Rekha Rao, PhD
Published Online:6:45 PM, Tue August 29, 2017

Rekha Rao, PhD, assistant professor, University of Kansas Medical Center, discusses the need to develop novel therapies in mantle cell lymphoma, including a study that explored the synergistic activity of p97 inhibitors with histone deacetylase 6 inhibitors.
Copyright © TargetedOnc 2018 Intellisphere, LLC. All Rights Reserved.